Breast cancer vaccine - Tel Aviv University
Latest Information Update: 24 Oct 2021
At a glance
- Originator Tel Aviv University
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 15 Feb 2008 Discontinued - Preclinical for Breast cancer in Israel (unspecified route)
- 08 Apr 1997 Preclinical development for Breast cancer in Israel (Unknown route)